Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction
Open Access
- 29 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Basic Research in Cardiology
- Vol. 106 (4), 527-538
- https://doi.org/10.1007/s00395-011-0179-7
Abstract
NADPH oxidase (Nox)-derived reactive oxygen species (ROS) are known to be involved in angiotensin II-induced hypertension and endothelial dysfunction. Several Nox isoforms are expressed in the vessel wall, among which Nox2 is especially abundant in the endothelium. Endothelial Nox2 levels rise during hypertension but little is known about the cell-specific role of endothelial Nox2 in vivo. To address this question, we generated transgenic mice with endothelial-specific overexpression of Nox2 (Tg) and studied the effects on endothelial function and blood pressure. Tg had an about twofold increase in endothelial Nox2 levels which was accompanied by an increase in p22phox levels but no change in levels of other Nox isoforms or endothelial nitric oxide synthase (eNOS). Basal NADPH oxidase activity, endothelial function and blood pressure were unaltered in Tg compared to wild-type littermates. Angiotensin II caused a greater increase in ROS production in Tg compared to wild-type aorta and attenuated acetylcholine-induced vasorelaxation. Both low and high dose chronic angiotensin II infusion increased telemetric ambulatory blood pressure more in Tg compared to wild-type, but with different patterns of BP change and aortic remodeling depending upon the dose of angiotensin II dose. These results indicate that an increase in endothelial Nox2 levels contributes to angiotensin II-induced endothelial dysfunction, vascular remodeling and hypertension.This publication has 28 references indexed in Scilit:
- A Radical View on the Contractile Machinery in Human Heart FailureJournal of the American College of Cardiology, 2011
- The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in miceBasic Research in Cardiology, 2010
- NADPH oxidases in cardiovascular diseaseFree Radical Biology & Medicine, 2010
- CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial functionBasic Research in Cardiology, 2010
- Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuationBasic Research in Cardiology, 2010
- gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular HypertensionCirculation, 2004
- NOX enzymes and the biology of reactive oxygenNature Reviews Immunology, 2004
- Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac HypertrophyCirculation Research, 2003
- Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Vascular Superoxide Production by NAD(P)H OxidaseCirculation Research, 2000